Search Orphan Drug Designations and Approvals
-
| Generic Name: | Ritonavir powder for oral suspension | |
|---|---|---|
| Trade Name: | Norvir Powder for Oral Suspension | |
| Date Designated: | 01/11/2017 | |
| Orphan Designation: | Use with other antiretroviral agents for the treatment of pediatric HIV-1 infection | |
| Orphan Designation Status: | Designated/Approved/Withdrawn | |
| Sponsor: |
AbbVie Inc. Regulatory Affairs 1 Waukegan Road North Chicago, Illinois 60044 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
| 1 | Generic Name: | Ritonavir powder for oral suspension |
|---|---|---|
| Trade Name: | Norvir Powder for Oral Suspension | |
| Marketing Approval Date: | 06/07/2017 | |
| Approved Labeled Indication: | Used in combination with other antiretroviral agents for the treatment of patients with HIV-1 infection | |
| Exclusivity End Date: | N/A | |
-
